Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P I Clark

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Cancer Treatment Reports|April 1, 1987
High-dose cytarabine in small cell lung cancerR J Osborne, P I Clark, M L Slevin, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|May 20, 1999
Anti-tobacco socialization in homes of African-American and white parents, and smoking and nonsmoking parentsP I Clark, A Scarisbrick-Hauser, S P Gautam, et al.
Tobacco Control|May 30, 2003
How tobacco companies ensure prime placement of their advertising and products in stores: interviews with retailers about tobacco company incentive programmesE C Feighery, K M Ribisl, P I Clark, et al.
Clinical Cardiology|February 1, 1992
Effect of diuretic therapy on the electrocardiographic response to exerciseE E Pascual, G B Cintron, M G Valdez, et al.
Annals of Epidemiology|November 1, 1996
Response error in self-reported current smoking frequency by black and white established smokersP I Clark, S P Gautam, W M Hlaing, et al.
European Journal of Biochemistry|September 15, 1977
Inhibition of papain by N-acyl-aminoacetaldehydes and N-acyl-aminopropanones. Evidence for hemithioacetal formation by a cross-saturation technique in nuclear-magnetic resonance spectroscopyM R Bendall, I L Cartwright, P I Clark, et al.
Tobacco Control|May 30, 2003
Development of a model of the tobacco industry's interference with tobacco control programmesW M K Trochim, F A Stillman, P I Clark, et al.
Oncology|October 13, 2001
A phase I trial of a 5-day schedule of intravenous topotecan and etoposide in previously untreated patients with small-cell lung cancerP O'Neill, P I Clark, D Smith, et al.
JAMA|August 6, 2000
Factors associated with tobacco sales to minors: lessons learned from the FDA compliance checksP I Clark, S L Natanblut, C L Schmitt, et al.
Cancer|November 1, 1992
Successful treatment of a primary endodermal sinus tumor of the liverJ S Whelan, W Stebbings, R A Owen, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Cancer Treatment Reports|April 1, 1987
High-dose cytarabine in small cell lung cancerR J Osborne, P I Clark, M L Slevin, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|May 20, 1999
Anti-tobacco socialization in homes of African-American and white parents, and smoking and nonsmoking parentsP I Clark, A Scarisbrick-Hauser, S P Gautam, et al.
Tobacco Control|May 30, 2003
How tobacco companies ensure prime placement of their advertising and products in stores: interviews with retailers about tobacco company incentive programmesE C Feighery, K M Ribisl, P I Clark, et al.
Clinical Cardiology|February 1, 1992
Effect of diuretic therapy on the electrocardiographic response to exerciseE E Pascual, G B Cintron, M G Valdez, et al.
Annals of Epidemiology|November 1, 1996
Response error in self-reported current smoking frequency by black and white established smokersP I Clark, S P Gautam, W M Hlaing, et al.
European Journal of Biochemistry|September 15, 1977
Inhibition of papain by N-acyl-aminoacetaldehydes and N-acyl-aminopropanones. Evidence for hemithioacetal formation by a cross-saturation technique in nuclear-magnetic resonance spectroscopyM R Bendall, I L Cartwright, P I Clark, et al.
Tobacco Control|May 30, 2003
Development of a model of the tobacco industry's interference with tobacco control programmesW M K Trochim, F A Stillman, P I Clark, et al.
Oncology|October 13, 2001
A phase I trial of a 5-day schedule of intravenous topotecan and etoposide in previously untreated patients with small-cell lung cancerP O'Neill, P I Clark, D Smith, et al.
JAMA|August 6, 2000
Factors associated with tobacco sales to minors: lessons learned from the FDA compliance checksP I Clark, S L Natanblut, C L Schmitt, et al.
Cancer|November 1, 1992
Successful treatment of a primary endodermal sinus tumor of the liverJ S Whelan, W Stebbings, R A Owen, et al.
Pageof 7